Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
254.89
+0.24 (+0.09%)
Streaming Delayed Price
Updated: 11:52 AM EDT, Jul 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,632,332
Open
253.25
Bid (Size)
254.79 (100)
Ask (Size)
254.99 (100)
Prev. Close
254.65
Today's Range
250.70 - 255.82
52wk Range
184.63 - 261.63
Shares Outstanding
N/A
Dividend Yield
2.71%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
5 Dividend Kings to Buy in July with Irristable Value and Yield
↗
Today 10:15 EDT
Five Dividend Kings—Procter & Gamble, Hormel, Stanley Black & Decker, Genuine Parts and Lowe's—trade at discounted valuations, offering attractive yields despite near-term business headwinds.
Via
MarketBeat
3 Reasons to Buy Novo Nordisk Stock
↗
July 07, 2026
The stock is down, but it isn't out yet.
Via
The Motley Fool
Performance
YTD
+11.2%
+11.2%
1 Month
+14.3%
+14.3%
3 Month
+23.5%
+23.5%
6 Month
+13.8%
+13.8%
1 Year
+35.8%
+35.8%
More News
Read More
U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend
↗
July 07, 2026
Via
The Motley Fool
Cannabis Theme Rally Powered by Profitability, Not Pure-Play Speculation
↗
July 03, 2026
Via
Chartmill
Topics
Cannabis
Abivax: Wall Street Catches Up to the Data
↗
July 07, 2026
Via
MarketBeat
3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List)
↗
July 07, 2026
Via
The Motley Fool
Topics
Intellectual Property
The Dividend ETF Quietly Outperforming the S&P 500
↗
July 07, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Is Apple Stock a Buy After Its Recent Pullback? Here's What History Suggests.
↗
July 07, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
3 Market-Beating Stocks Worth Investigating
July 07, 2026
Via
StockStory
Wall Street Got the Weak Jobs Report It Wanted. Chip Stocks Wrecked the Rally Anyway.
↗
July 06, 2026
Via
Chartmill
Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
July 02, 2026
Via
StockStory
Topics
Artificial Intelligence
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today
↗
July 01, 2026
Via
Benzinga
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
July 01, 2026
From
Biotech Insider
Via
GlobeNewswire
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?
↗
June 30, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 No-Brainer Dividend Stocks to Buy Right Now
↗
June 29, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?
↗
June 29, 2026
Via
The Motley Fool
2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky
June 29, 2026
Via
StockStory
Topics
Retirement
Stocks
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?
↗
June 25, 2026
Via
The Motley Fool
Topics
Intellectual Property
Is AbbVie a Buy After Its Purchase of Apogee?
↗
June 25, 2026
Via
The Motley Fool
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026
From
Biotech Insider
Via
GlobeNewswire
Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years
↗
June 24, 2026
Via
Benzinga
2 Value Stocks Worth Your Attention and 1 Facing Headwinds
June 24, 2026
Via
StockStory
3 Monster Stocks to Hold for the Next 10 Years
↗
June 23, 2026
Via
The Motley Fool
Topics
Intellectual Property
Why AbbVie Stock Jumped Today
↗
June 22, 2026
Via
The Motley Fool
AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?
↗
June 22, 2026
Via
The Motley Fool
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 254.89
When was AbbVie last traded?
The last trade of AbbVie was at 07/08/26 11:52 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.